Wnt1 as a renal damage biomarker

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/68 (2006.01)

Patent

CA 2733964

The present invention comprises the use of WNT1 as a biomarker in the monitoring, prognosis and /or in the diagnosis of chronic nephropathies. It provides in vitro prognostic and diagnostic methods and kits for its implementation. The present invention also comprises the use of WNT1 in screening active ingredients for the manufacture of a drug for therapies for chronic nephropathies and a method for conducting said screening.

La présente invention concerne lutilisation de WNT1 en tant que biomarqueur dans la surveillance, le pronostic et/ou le diagnostic de néphropathies chroniques. La présente invention concerne des procédés et des trousses de pronostic et de diagnostic in vitro pour sa mise en uvre. La présente invention concerne en outre lutilisation de WNT1 dans le criblage de principes actifs pour la fabrication dun médicament pour des thérapies pour des néphropathies chroniques et un procédé pour conduire ledit criblage.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Wnt1 as a renal damage biomarker does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Wnt1 as a renal damage biomarker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Wnt1 as a renal damage biomarker will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1960220

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.